![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2022
Anzahl der Publikationen: 4
2022
Leyh, Catherine; Ehmer, Ursula; Rössler, Daniel; Philipp, Alexander B.; Reiter, Florian P.; Jeliazkova, Petia; Jochheim, Leonie S.; Jeschke, Matthias; Hammig, Janina; Ludwig, Johannes M.; Theysohn, Jens M.; Geier, Andreas und Lange, Christian M.
(2022):
Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World Analysis.
In: Cancers, Bd. 14, Nr. 8
[PDF, 1MB]
Theysohn, Jens M.; Demircioglu, Aydin; Kleditzsch, Malte; Ludwig, Johannes M.; Weber, Manuel; Umutlu, Lale; Li, Yan; Kircher, Malte; Lapa, Constantin; Buck, Andreas; Koehler, Michael; Wildgruber, Moritz; Lange, Christian M.; Palard, Xavier; Garin, Etienne; Herrmann, Ken; Forsting, Michael und Nensa, Felix
(2022):
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation.
In: Scientific Reports, Bd. 12, Nr. 1, 20718
de Castro, Tiago; Jochheim, Leonie S.; Bathon, Melanie; Welland, Sabrina; Scheiner, Bernhard; Shmanko, Kateryna; Roessler, Daniel; Ben Khaled, Najib; Jeschke, Matthias; Ludwig, Johannes M.; Marquardt, Jens U.; Weinmann, Arndt; Pinter, Matthias; Lange, Christian M.; Vogel, Arndt und Saborowski, Anna
(2022):
Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience.
In: Therapeutic Advances in Medical Oncology, Bd. 14
Leyh, Catherine; Heucke, Niklas; Schotten, Clemens; Büchter, Matthias; Bechmann, Lars P.; Wichert, Marc; Dechene, Alexander; Herrmann, Ken; Heider, Dominik; Sydor, Svenja; Lemmer, Peter; Ludwig, Johannes M.; Pospiech, Josef; Theysohn, Jens; Damm, Robert; March, Christine; Powerski, Maciej; Pech, Maciej; Oezcueruemez, Mustafa; Weigt, Jochen; Keitel, Verena; Lange, Christian M.; Schmidt, Hartmut; Canbay, Ali; Best, Jan; Gerken, Guido und Manka, Paul P.
(2022):
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis.
In: Cancers, Bd. 14, Nr. 19, 4584